Introduction
============

Cervical cancer is one of the most common female malignancies. In certain developing countries, cervical cancer has the highest incidence; however, in North America and Europe, the incidence is far lower than the incidences of breast cancer, endometrial cancer and ovarian cancer. According to the estimates of the International Cancer Research Center, there are ∼371,200 new cases of cervical cancer, accounting for ∼9.8% of all tumors and 15% of female cancers annually ([@b1-etm-06-01-0085]). Of them, 78% of new cases appear in developing countries, while only ∼4.4% occur in developed countries. Annually, there are ∼100,000 new cases of cervical cancer in China, accounting for 1/4 of the global incidence of cervical carcinoma and ranking first in the prevalence of gynecological malignancies ([@b2-etm-06-01-0085]). In certain developing countries, cervical cancer is the leading cause of mortality for females. In developed countries, the incidence is significantly reduced. In certain countries, the mortality rate of cervical cancer has been reduced by \>50% as a result of the early diagnosis and treatment of cervical precancerous lesions ([@b3-etm-06-01-0085],[@b4-etm-06-01-0085]). A number of studies have demonstrated that cervical cancer is associated with human papilloma virus (HPV) infection, particularly the high-risk HPV genotypes ([@b5-etm-06-01-0085]--[@b7-etm-06-01-0085]).

At present, a HPV genotyping assay has been adopted in developed regions as a main method for screening cervical lesions. A HPV vaccine is currently the first choice for the prevention of HPV infection and consequent reduction of the incidence of cervical cancers. Research on HPV vaccines is mainly targeted at high-risk HPV genotypes. It is reported that persistent infection with HPV is the crucial factor for cervical cancer ([@b8-etm-06-01-0085]). To investigate the results of the HPV vaccine and HPV examination-based screening for cervical cancer prevention, HPV infection in large population requires examination.

A preliminary epidemiological study has investigated different genotypes of HPV infection in a number of regions in China ([@b9-etm-06-01-0085]). However, in Xinjiang, where the incidence of cervical cancer is highest, there have been no region-based population surveys of HPV infection. In the current study, the analysis of female HPV infection in the Urumqi district of Xinjiang was examined, including assessment of age and genotype distribution. This study provides scientific evidence for the HPV vaccine prevention plan and support for an effective cervical cancer prevention strategy.

Subjects and methods
====================

Subjects
--------

Females aged 18--69 years in the Urumqi Saybagh district were recruited. All patients provided informed consent. The subjects were divided into four groups, including 543 migrant workers, 525 white-collar workers (government employees, employees in institutionalized organizations and managers in companies), 487 workers in service industries and 714 community residents with a total of 2,269. By the stratified cluster random sampling method, age-stratified sampling was also applied in selected populations, with every 5 years as the age group. Prior written and informed consent were obtained from every patient and the study was approved by the ethics review board of First Affiliated Hospital of Xinjiang Medical University (Urumqi, China).

Instruments and reagents
------------------------

A HPV nucleic acid amplification typing detection reagent kit was purchased from Cape Biochemistry Ltd., Co. (Guangdong, China). A HybriMax medical nucleic acid molecule rapid hybridization instrument, an Autocyte Prep system for liquid-based cytology, CytoRich Preservative fluid and an electronic colposcope were purchased from Shenzhen Goldway Industrial Inc. (Shenzhen, China).

HPV detection
-------------

All subjects underwent gynecological examination and cervical secretion was collected. A genome extraction kit from Cape Biochemistry Ltd., Co. was used for DNA extraction. Polymerase chain reaction (PCR) amplification using the ABI7300 PCR amplification instrument (Cape Biochemistry Ltd. Co.) and hybridization were performed. Results were obtained by visual observation. A clear blue purple dot was considered positive. According to the film HPV genotype distribution map, the HPV subtype was determined. If the two control points were positive and other points were negative, DNA test results of HPV subtypes in the reagent kit were considered negative. If at least one HPV genotype point was positive, it demonstrated single or mixed HPV infection.

Liquid-based cytology test (LCT)
--------------------------------

An AutoCyte liquid-based thin-film machine (TriPath Imaging Inc., BD Diagnostics, Burlington, NC, USA) was used for automatic production and dyeing. Results were examined by optical microscopy and cytological diagnosis was in accordance with The Bethesda System (TBS, 2001) ([@b10-etm-06-01-0085]).

Colposcopy and pathological diagnosis
-------------------------------------

For all the subjects with abnormal LCT results, colposcopy and biopsy were performed. For positive high-risk HPV infection in cervical secretions with atypical squamous cells of undetermined sign and/or low-grade squamous intraepithelial lesions in the LCT or worse, colposcopy was performed again. Biopsy was performed by electronic colposcopy in suspicious lesions for pathological diagnosis.

Statistical analysis
--------------------

VFP software was used for database building (Microsoft Corp, Redmond, WA, USA). SPSS 16.0 software (SPSS, Inc., Chicago, IL, USA) was used for statistical analysis. Data are presented as the mean ± standard error of the mean (SEM). The HPV infection rates in different age groups with different occupations, cervical intraepithelial neoplasia (CIN; a premalignant cervical disease) rate comparison of different levels and cervical lesion HPV detection rate comparison of different degrees from pathological results were examined by χ^2^ test. Single factor analysis was performed for each factor and analyzed by the logistic regression model. P\<0.05 was considered to indicate a statistically significant result.

Results
=======

Detected rates of different HPV genotypes in cervical lesions of females of different ages
------------------------------------------------------------------------------------------

In this study, 2,269 females were enrolled with an average age of 39.65±0.203 years, ranging from 18 to 69 years. The subjects included 543 migrant workers (individuals going to Urumqi region to work from the other areas of China) with an average age of 35.60±0.612 years, 525 white-collar workers (government employees, employees in institutionalized organizations and managers in companies) with an average age of 34.90±0.319 years, 487 workers in service industries with an average age of 32.78±0.364 years and 714 community residents with an average age of 43.60±0.225 years.

As shown in [Table I](#t1-etm-06-01-0085){ref-type="table"}, there were 460 positive cases of HPV, with a detection rate of 20.27% in the whole investigated group in this study. A total of 21 HPV genotypes were detected, including 13 high-risk genotypes: HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68; five low-risk genotypes: HPV-6, 11, 42, 43, 44; and three common genotypes of Chinese individuals: HPV-53, 56 and CP8304. For the females with infections of high-risk HPV genotypes, the high-risk HPV genotypes were mainly HPV-16, 58, 52 and 18, which accounted for 43.35, 18.35, 8.86 and 7.59%, respectively, of the total infection. The four genotypes accounted for 78.16% of the high-risk HPV genotypes.

As shown in [Fig. 1A](#f1-etm-06-01-0085){ref-type="fig"}, the high-risk HPV-positive rates in the three age groups (18--34, 35--44 and 45--69 years) were 18.07, 29.64 and 7.64% (χ^2^=105.02, P\<0.05), respectively. The differences in the high-risk HPV-positive rates in the three age groups were significant (χ^2^=19.43, P\<0.05; χ^2^=22.62, P\<0.01; and χ^2^=66.17, P\<0.01, respectively).

HPV-positive rates are higher among the groups with deteriorating cervical lesions
----------------------------------------------------------------------------------

To determine whether HPV infection is related to different degrees of cervical lesions, HPV infection was determined in the patients with different degrees of cervical lesions. As shown in [Fig. 1B](#f1-etm-06-01-0085){ref-type="fig"}, the HPV-positive rate in normal groups without symptoms of cervical lesions was ∼9%. The HPV-positive rates in chronic cervicitis and CIN I patients were ∼49 and 70%, respectively. The HPV-positive rates in CIN II and CIN III patients were ∼79 and 95%, respectively. However, the HPV-positive rate in cervical cancer patients was ∼100%. These results suggest that HPV infection rates are increased in groups with deteriorating cervical lesions (χ^2^=697.72, P\<0.05).

Comparison of the HPV infection rates among different occupation groups
-----------------------------------------------------------------------

The HPV infection rates in patients with different occupations were also investigated. As shown in [Fig. 2](#f2-etm-06-01-0085){ref-type="fig"}, the 35--44-year-old migrant worker group had the highest HPV infection rates among all the groups in the three different age ranges. The HPV infection rate of females in service industries was significantly higher compared with those of the white-collar workers, community residents and migrant worker groups (χ^2^=74.46, P\<0.05; χ^2^=84.93, P\<0.05; and χ^2^=13.41, P\<0.05, respectively) at all three age ranges. These results suggest that the 35--44-year-old migrant worker group and the service industry workers may have a higher risk of HPV infection.

Analyses of the high-risk HPV infections
----------------------------------------

To investigate the factors related to the HPV infections, single analysis was performed to study the related factors by comparing data between the HPV-positive and HPV-negative groups. As shown in [Table II](#t2-etm-06-01-0085){ref-type="table"}, several factors, including the number of marriages, education level, smoking history, number of abortions, condom use, number of sexual partners and number of sexual partners within the last 5 years, as well as occupation were significantly different between the two groups (P\<0.05; [Table II](#t2-etm-06-01-0085){ref-type="table"}). This analysis indicates that the number of marriages, education level, smoking history, number of abortions, use of condoms, number of sexual partners, number of sexual partners in the past five years and occupation were associated with HPV infection rates (P\<0.05).

To further confirm the results, logistic regression model analysis was performed on variables with statistical significance in univariate analysis (α in=0.05, α out=0.10; in, the inclusion criteria; out, the exclusion criteria). The data in [Table III](#t3-etm-06-01-0085){ref-type="table"} shows that education level, number of sexual partners, condom use and occupation were incorporated into the model. The results suggest that education level and condom use were two protective factors of HPV infection, while the number of sexual partners and occupation were risk factors for HPV infection.

Discussion
==========

In this study, a stratified cross-sectional survey was performed to conduct genotyping detection of 21 types of HPV in a large sample. The distribution of HPV-DNA subtypes varies in different districts and ethnic groups. de Sanjosé *et al* ([@b11-etm-06-01-0085]) conducted a meta-analysis of HPV infection in six regions of the world in 157,879 females without cervical lesions (by cytological diagnosis). The HPV infection rate was ∼10.4%.

The prevalence of HPV infection varies significantly. The HPV infection rates are as follows: 22.1% in Africa, 20.4% in the central United States and Mexico, 11.3% in North America, 8.1% in Europe and 8.0% in Asia ([@b11-etm-06-01-0085]). Bell *et al* ([@b12-etm-06-01-0085]) determined the mean HPV infection rate of 287 American Indian females (by PCR assay) to be 21.25%. Of these, 67.2% was high-risk HPV infection and 41% was multiple infection, and the common HPV infection subtypes were HPV-59, 39 and 73. In China, Li and Dai ([@b13-etm-06-01-0085]) conducted a study to determine the HPV infection rate in three regions of Shanxi, Shenyang and Shenzhen. The authors identified that the HPV infection rate was 16.1% and HPV-16 is the most common virus type, followed by HPV-58, 52 and 18 ([@b13-etm-06-01-0085]). In the present study, we identified that the HPV infection rate in Urumqi, Xinjiang is 20.27%, higher than that of Europe and the results of the study by Li and Dai, and similar to that of American Indian females, which may be explained by the fact that Xinjiang is an area with a high incidence of cervical cancer. We demonstrated that the common subtypes in Urumqi, Xinjiang are HPV-16, 58, 52 and 18, which is similar to the results of the study by Li and Dai ([@b8-etm-06-01-0085]). The existing vaccines are only effective for subtypes 16 and 18; however, 58 and 52 are also highly prevalent. Therefore, a customized HPV vaccine is required for the prevention and treatment of cervical lesions in Chinese females.

In a number of developed countries, including Spain and South Korea, the HPV infection peak usually occurs in young individuals under the age of 25 years and it declines sharply as age increases. In certain areas of South America, the HPV infection rate of 35--54-year-olds is lower than that of younger individuals (\<25 years) and elderly individuals (\>55 years). In countries with a high incidence of cervical cancer, including India and Nigeria, the HPV infection rate of individuals aged 35--54 years is higher than that in younger individuals (\<25 years) and elderly individuals (\>55 years) ([@b14-etm-06-01-0085]). In the present study, we identified that that the infection rate of individuals aged 35--44 years is significantly higher than that in younger individuals (18--34 years) and elderly individuals (\>45 years). The infection rate of HPV in the younger individuals was significantly higher than that in the elderly group. Our results are similar to data in India and Nigeria, but different from data in developed countries including Spain and South Korea. The high infection rate in the 35 to 44 age group was possibly due to the reason that females in that age group are sexually active.

HPV infection rates were increased with aggravated cervical lesions. The HPV infection rate in cervical cancer was 100%, demonstrating again the correlation between cervical cancer and HPV infection. HPV infection rates in different age groups with different professions were also examined. The HPV infection rate of workers in service industries was significantly higher than the infection rates of white-collar workers, community residents and migrant workers. Among workers in service industries, the HPV infection rate of females aged 18--34 years was higher than that of those aged 35--44 and 45--69 years. This indicates that female workers in service industries aged 18--34 years are the most sexually active. A lack of health protection is a possible reason for the high HPV infection rate.

In this study, we identified that the number of marriages, education level, smoking history, number of abortions, condom use, number of sexual partners, number of sexual partners in the past five years and occupation are risk factors for HPV infection. A large number of epidemiological studies have shown that a premature sex life, multiple sexual partners, unprotected sexual intercourse and abortion increase the risk of cervical cancer ([@b15-etm-06-01-0085]--[@b17-etm-06-01-0085]). One study reported that as the smoking time increases, the risk of cervical cancer increases ([@b18-etm-06-01-0085]). In the current study, smoking was also observed to be a risk factor for HPV infection. The use of condoms avoids cross-infection, thus reducing the prevalence of HPV.

In conclusion, the infection rate of HPV is high in Urumqi, Xinjiang, with HPV-16, 58, 52 and 18 as the common genotypes. Since females aged 35--44 years have the highest rate of infection, screening of cervical lesions and health habit guidance should be performed.
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###### 

Distribution of HPV genotypes infecting females in Urumqi.

  HPV genotype              Total positive cases   Positive ratio of population[^a^](#tfn1-etm-06-01-0085){ref-type="table-fn"}   Positive ratio of group[^a^](#tfn1-etm-06-01-0085){ref-type="table-fn"}
  ------------------------- ---------------------- ------------------------------------------------------------------------------ -------------------------------------------------------------------------
  High-risk                                                                                                                       
    HPV-16                  137                    137/2269 (6.03)                                                                137/316 (43.35)
    HPV-18                  24                     24/2269 (1.05)                                                                 24/316 (7.59)
    HPV-31                  21                     21/2269 (0.93)                                                                 21/316 (6.65)
    HPV-33                  13                     13/2269 (0.57)                                                                 13/316 (4.11)
    HPV-35                  0                      0                                                                              0
    HPV-39                  10                     10/2269 (0.44)                                                                 10/316 (3.16)
    HPV-45                  5                      5/2269 (0.22)                                                                  5/316 (1.58)
    HPV-51                  5                      5/2269 (0.22)                                                                  5/316 (1.58)
    HPV-52                  28                     28/2269 (1.23)                                                                 28/316 (8.86)
    HPV-56                  5                      5/2269 (0.22)                                                                  5/316 (1.58)
    HPV-58                  58                     58/2269 (2.56)                                                                 58/316 (18.35)
    HPV-59                  0                      0                                                                              0
    HPV-68                  10                     10/2269 (0.44)                                                                 10/316 (3.16)
  Low-risk                                                                                                                        
    HPV-6                   5                      5/2269 (0.22)                                                                  5/14 (35.71)
    HPV-11                  3                      3/2269 (0.13)                                                                  3/14 (21.43)
    HPV-42                  3                      3/2269 (0.13)                                                                  3/14 (21.43)
    HPV-43                  3                      3/2269 (0.13)                                                                  3/14 (21.43)
    HPV-44                  0                      0                                                                              0
  Common type for Chinese                                                                                                         
    HPV-53                  10                     10/2269 (0.44)                                                                 10/30 (33.33)
    HPV-66                  10                     10/2269 (0.44)                                                                 10/30 (33.33)
    HPV-CP8304              10                     10/2269 (0.44)                                                                 10/30 (33.33)
  Mixed infection           100                    100/2269 (4.41)                                                                100/100 (100.0)
  Total                     460                                                                                                   

Values in brackets are percentages. HPV, human papillomavirus.

###### 

Single factor analysis of the risk factors of HPV infection.

  Variables                                       HPV-positive cases   HPV-negative cases   OR value                                                95% CI
  ----------------------------------------------- -------------------- -------------------- ------------------------------------------------------- --------------
  Number of marriages                                                                                                                               
    0                                             70                   133                  1                                                       
    1                                             471                  1405                 0.632[^a^](#tfn2-etm-06-01-0085){ref-type="table-fn"}   0.408--1.001
    ≥2                                            93                   97                   1.786[^a^](#tfn2-etm-06-01-0085){ref-type="table-fn"}   1.022--3.369
  Education level                                                                                                                                   
    Junior high school or below                   464                  863                  1                                                       
    High school or above                          169                  773                  0.369[^a^](#tfn2-etm-06-01-0085){ref-type="table-fn"}   0.304--0.601
  Married                                                                                                                                           
    Yes                                           551                  1445                 1                                                       
    No                                            82                   191                  0.854                                                   0.534--1.313
  History of cervical disease                                                                                                                       
    Yes                                           384                  982                  1                                                       
    No                                            250                  653                  1.019                                                   0.765--1.343
  Tuberculosis                                                                                                                                      
    Yes                                           4                    8                    1                                                       
    No                                            630                  1627                 1.289                                                   0.231--7.083
  History of STDs                                                                                                                                   
    Yes                                           25                   55                   1                                                       
    No                                            609                  1580                 1.187                                                   0.587--2.402
  History of smoking                                                                                                                                
    No                                            303                  904                  1                                                       
    Yes                                           331                  731                  1.349[^a^](#tfn2-etm-06-01-0085){ref-type="table-fn"}   1.039--1.771
  Age of first menstruation                                                                                                                         
    ≤11 years                                     106                  297                  1                                                       
    12--15 years                                  432                  1078                 1.133                                                   0.791--1.622
    ≥16 years                                     95                   261                  1.041                                                   0.641--1.649
  Menopause                                                                                                                                         
    Yes                                           93                   233                  1                                                       
    No                                            541                  1402                 1.032                                                   0.712--1.523
  Abortion                                                                                                                                          
    Yes                                           74                   231                  1                                                       
    No                                            560                  1404                 0.811                                                   0.532--1.201
  Number of abortions                                                                                                                               
    1                                             184                  598                  1                                                       
    2                                             237                  545                  1.415[^a^](#tfn2-etm-06-01-0085){ref-type="table-fn"}   1.024--1.961
    ≥3                                            212                  493                  1.406[^a^](#tfn2-etm-06-01-0085){ref-type="table-fn"}   1.001--1.972
  Condom use                                                                                                                                        
    Yes                                           216                  666                  1                                                       
    No                                            418                  969                  1.334[^a^](#tfn2-etm-06-01-0085){ref-type="table-fn"}   1.005--1.761
  Number of sexual partners                                                                                                                         
    1                                             500                  1430                 1                                                       
    2                                             91                   140                  1.855[^a^](#tfn2-etm-06-01-0085){ref-type="table-fn"}   1.231--2.807
    ≥3                                            42                   66                   1.901[^a^](#tfn2-etm-06-01-0085){ref-type="table-fn"}   1.603--3.422
  Number of sexual partners in the past 5 years                                                                                                     
    1                                             479                  1366                 1                                                       
    2                                             87                   157                  1.577[^a^](#tfn2-etm-06-01-0085){ref-type="table-fn"}   1.042--2.376
    ≥3                                            67                   113                  1.749[^a^](#tfn2-etm-06-01-0085){ref-type="table-fn"}   1.103--2.789
  Sexual intercourse outside marriage                                                                                                               
    Yes                                           50                   140                  1                                                       
    No                                            583                  1496                 0.933                                                   0.569--1.523
  Age at first sexual intercourse                                                                                                                   
    ≤18 years                                     129                  295                  1                                                       
    19--22 years                                  224                  668                  0.761                                                   0.524--1.121
    ≥23 years                                     280                  673                  0.931                                                   0.637--1.336
  Occupation                                                                                                                                        
    Community residents                           91                   623                  1                                                       
    White-collar workers                          64                   461                  1.902                                                   0.831--1.743
    Migrant workers                               134                  409                  3.288[^a^](#tfn2-etm-06-01-0085){ref-type="table-fn"}   2.241--4.851
    Workers in service industry                   171                  316                  3.995[^a^](#tfn2-etm-06-01-0085){ref-type="table-fn"}   2.473--5.247

P\<0.05. HPV, human papillomavirus; OR, odds ratio; CI, confidence interval; STDs, sexually transmitted diseases.

###### 

Multiple factor analysis of the risk factors of HPV infection.

  Factor                      B        SE      Wald     df   P-value   Exp(B)   95% CI for Exp(B)   
  --------------------------- -------- ------- -------- ---- --------- -------- ------------------- -------
  Education level             −0.871   0.152   32.233   1    0.000     0.423    0.301               0.559
  Number of sexual partners   0.326    0.133   5.923    1    0.012     1.379    1.062               1.791
  Condom use                  −0.372   0.146   6.238    1    0.009     0.681    0.509               0.919
  Occupation                  0.453    0.061   51.949   1    0.000     1.581    1.389               1.778

B, partial regression coefficient; Wald, Wald χ^2^ test; df, degree of freedom; Exp (B), exponentiation of the B coefficient; CI, confidence interval; HPV, human papillomavirus.
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